✦ LIBER ✦

Schistosomiasis as an important determining factor for the response of Egyptian patients with chronic hepatitis C to therapy with recombinant human α-2 interferon

✍ Scribed by Yehia El-Shazly; Abdel-Fatah Abdel-Salam; Aisha Abdel-Ghaffar; Zakaria Mohran; Saleh M. Saleh

Book ID: 103365763
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 432 KB
Volume: 88
Category: Article
ISSN: 0035-9203
DOI: 10.1016/0035-9203(94)90310-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genotype, serum level of hepatitis C vir

Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-α 2α therapy in Japanese patients with chronic hepatitis C

✍ Masashi Mizokami; Etsuro Orito; Yukio Gibo; Kaoru Suzuki; Ken-ichi Ohba; Tomoyos 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

Predictive factors regarding the respons

Predictive factors regarding the responsiveness to interferon therapy for patients with chronic hepatitis C: an assessment of the hypervariable region 1 quasispecies in genotype 1b of chronic hepatitis C

✍ Kyoko Harada; Hiroshi Watanabe; Hiroshi Shijo; Makoto Okumura 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Usefulness of simple assays for serum co

Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy

✍ Toshio Suzuki; Eiji Tanaka; Akihiro Matsumoto; Akihiko Urushihara; Takeshi Sodey 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4

Risk factors for the development of hepa

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

✍ HAJIME TOKITA; HIDEO FUKUI; AKIHISA TANAKA; HIROSHI KAMITSUKASA; MICHIYASU YAGUR 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Efficacy of an analysis of lymphocyte su

Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to α-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study

✍ Giovanna Russo-Mancuso; Felicia Di Gregorio; Enrica Passero; Antonella Sciotto; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Randomized trial of high-dose interferon

Randomized trial of high-dose interferon-α-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

✍ Nami Mori; Michio Imamura; Yoshiiku Kawakami; Hiromi Saneto; Tomokazu Kawaoka; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

## Abstract The aim of this study was to compare the efficacy of high‐dose interferon (IFN)‐α‐2b with standard dose of IFN‐α‐2b in combination with ribavirin (RBV) for patients with chronic hepatitis C virus (HCV) infection, and to investigate the predictive factors associated with virological resp